🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ramya Tunuguntla

Stanford Medicine

ORCID: 0000-0003-0705-7483

Also affiliated with Stanford University

EngineeringMedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study”.

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

The Lancet(2024)10.1016/s0140-6736(24)00746-3

N/A

1.4DataRank · unranked

60 citations

John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown +43 more

Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing

Molecular Cancer(2023)10.1186/s12943-023-01799-7

N/A

1.1DataRank · unranked

42 citations

Vimal Keerthi, Nikolaos Gkitsas, Andrew G. Mancini, Gavin Kurgan, Carley Fowler +12 more

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies

Cytotherapy(2025)10.1016/j.jcyt.2025.09.013

N/A

0DataRank · unranked

0 citations

Anne Marijn Kramer, Bonnie Yates, Hao‐Wei Wang, Bita Sahaf, Constance M. Yuan +28 more